145 related articles for article (PubMed ID: 14606290)
1. [Kidney failure, proteinuria, and diabetic nephropathy].
Collart F
Rev Med Brux; 2003 Sep; 24(4):A257-62. PubMed ID: 14606290
[TBL] [Abstract][Full Text] [Related]
2. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Cantarovich F; Rangoonwala B
Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
Lewis EJ; Lewis JB
J Am Soc Nephrol; 2004 May; 15(5):1358-60. PubMed ID: 15100380
[No Abstract] [Full Text] [Related]
5. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
Harman-Boehm I
Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
[No Abstract] [Full Text] [Related]
6. [The early diagnosis of kidney failure in diabetic patients and the new developments in its treatment].
Eliseev OM
Ter Arkh; 1995; 67(4):66-9. PubMed ID: 7784984
[No Abstract] [Full Text] [Related]
7. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
8. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
[TBL] [Abstract][Full Text] [Related]
9. The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.
Gansevoort RT; Apperloo AJ; Heeg JE; de Jong PE; de Zeeuw D
Arch Intern Med; 1992 Oct; 152(10):2137-9. PubMed ID: 1417388
[No Abstract] [Full Text] [Related]
10. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Wade VL; Gleason BL
Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
[TBL] [Abstract][Full Text] [Related]
11. Benazepril and the kidney: new indication. No better than the other ACE inhibitors.
Prescrire Int; 1998 Dec; 7(38):174-6. PubMed ID: 10848048
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
13. Proteinuria, a modifiable risk factor: angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs).
Dykeman-Sharpe J
CANNT J; 2003; 13(4):34-6; quiz 37-8. PubMed ID: 14753101
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blockade in diabetic nephropathy.
Andersen S
Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
[No Abstract] [Full Text] [Related]
15. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
Esnault V
Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
[TBL] [Abstract][Full Text] [Related]
16. Effects of different antihypertensive drugs on human diabetic proteinuria.
Weidmann P; Boehlen LM; de Courten M
Nephrol Dial Transplant; 1993; 8(7):582-4. PubMed ID: 8396739
[No Abstract] [Full Text] [Related]
17. [Threatened diabetic nephropathy. Early administration of ACE inhibitors and AT1 blockers].
Einecke U
MMW Fortschr Med; 2002 Apr; 144(15):14. PubMed ID: 12004443
[No Abstract] [Full Text] [Related]
18. Screening and treatment of diabetic renal disease.
Clement JD; Cottiero RA
Med Health R I; 1998 Nov; 81(11):348-9. PubMed ID: 15580788
[No Abstract] [Full Text] [Related]
19. Toward better renoprotection: lessons from angiotensin receptor blockers.
Miyata T; Takizawa S
Hemodial Int; 2007 Apr; 11(2):164-8. PubMed ID: 17403166
[TBL] [Abstract][Full Text] [Related]
20. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
